| Name | Title | Contact Details |
|---|
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Shore Health System provides an array of programs to attract, educate, and transition new and returning nurses.
Centro Latino de Chelsea is a Chelsea, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CAnCare of Houston is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Babeskin Bodycare is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.